Correlation between the function of monocytes/macrophages and disease progression in people living with HIV/AIDS in several provinces in China

National Medical Journal of China

Volumn 87, Issue 34, 2007, Pages 2394-2397

  Zhou, Li Ping ^a   Shang, Hong ^a   Zhang, Zi Ning ^a   Wang, Ya Nan ^a   Li, Ge Fei ^a   Shi, Wan Ying ^a   Ding, Hai Bo ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Acquired immunodeficiency syndrome; HIV; Macrophages; Monocytes

Indexed keywords

CD14 ANTIGEN; CD4 ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; VIRUS RNA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ANTIGEN EXPRESSION; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MAJOR CLINICAL STUDY; MALE; MONOCYTE; PHAGOCYTOSIS; REAL TIME POLYMERASE CHAIN REACTION; STATISTICAL SIGNIFICANCE; T LYMPHOCYTE; VIRUS LOAD;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADULT; ANTIGENS, CD; ANTIGENS, CD14; ANTIGENS, CD4; ANTIGENS, DIFFERENTIATION, T-LYMPHOCYTE; CD4-POSITIVE T-LYMPHOCYTES; CHINA; FEMALE; FLOW CYTOMETRY; HIV INFECTIONS; HUMANS; MACROPHAGES; MALE; MIDDLE AGED; MONOCYTES; RNA, VIRAL; VIRAL LOAD;

EID: 37149046731     PISSN: 03762491     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Nottet HS, de Graaf L, Machiel de Vos N, et al. Down-regulation of human immunodeficiency virus type (HIV-1) production after stimulation of monocyte-derived macrophages infected with HIV-1. J Infect Dis, 1993, 167:810-817.
2. Biggs BA, Hewish M, Kent S, et al. HIV-1 infection of human macrophages impairs phagocytosis and killing of Toxoplasma gondii. J Immunol, 1995, 154:6132-6139.
3. Devadas K, Hardegen NJ, Wahl LM, et al. Mechanisms for macrophage-mediated HIV-1 induction. J Immunol, 2004, 173: 6735-6744.
4. + lymphocyte counts in patients with uncontrolled HIV infection. J Infect Dis, 2003, 1188:1804-1814.
5. Soumelis V, Scott I, Gheyas F, et al. Depletion of circulating natural type 1 interferon-producing cells in HIV-infected AIDS patients. Blood, 2001, 98: 906-912.
6. Levy JA, Scott I, Mackewiez C, et al. Protection from HIV/AIDS: the importance of innate immunity. Clinical Immunology, 2003, 108:167-174.
7. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep, 1992, 41:1-19
8. Chinese source.
9. Haynes BF, Pantalco G, Fauci AS, et al Toward an understanding of the correlates of protective immunity to HIV infection. Science, 1996, 271:324-328.
10. Williams KC, Hickey WF. Central never system damage, monocytes and macrophages and neurological discorders in AIDS. Annu Rev Neurosci, 2002, 25:537-562.
11. Glass JD, Wesselingh SL. Microglia in HIV-associated neurological diseases. Microsc Res Tech, 2001, 54:95-105.
12. Kusdra L, McGuire D, Pulliam L, Changes in monocyte/macrophage neurotoxicity in the era of HAART: implications for HIV-associated dementia. AIDS, 2002, 16:31-38.
13. Duan XZ, Wang M, Li HW, et al. Decreased frequency and function of circulating plasmocytoid dendritic cells (pDCs) in hepatitis B virus infected humans. J Clin Immunol, 2004, 24: 637-646.
14. Schmidt B, Scott I, Whitmore RG, et al. Low-level HfV infection of plasmycitoid dendritic cells: onset of cytopathic effects and cell death after PDC maturation. Vironogy, 2004, 329:280-288.
15. Norris PJ, Pappalardo BL, Custer B, et al. Elevations in IL-10, TNF-alpha,and IFN-gamma from the earliest point of HIV Type 1 infection. AIDS Res Hum Retroviruses, 2006, 22:757-762.
16. Brabers NA, Nottet HS. Role of the pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia. Eur J Clin Invest, 2006, 36:447-458.
17. + T-cells predict functional responses to immunizations in chronic HIV-1 infectio. AIDS, 2003, 17:2015-2023.
18. Stone SF, Price P, Keane NM, et al. Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART. HIV Med, 2002, 3:21-27.